Objective To obtain human receptor associated protein and to optimize its expression con-ditions. Methods RAP cDNA was inserted into prokaryotic expression vector-pT7-PL and pET-28a ( + ) to construct two RAP recombinant human RAP expression plasmids. After they were transformed to the BL21 strains, the transformed strains were induced with isopropylthiogalactoside (IPTG). The pT7-PL-RAP was selected for optimal expression, and Ni' -nitrilotriacetic acid (Ni-NTA) affinity chromatogram was applied for purification of RAP. The biological activity of RAP was assessed by detecting its binding abil...